Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

57.48
-0.6300-1.08%
Post-market: 57.900.4200+0.73%19:57 EDT
Volume:65.85M
Turnover:3.78B
Market Cap:117.02B
PE:16.61
High:58.55
Open:58.26
Low:56.91
Close:58.11
52wk High:62.89
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:5.73
T/O Rate:3.24%
Dividend:2.49
Dividend Rate:4.33%
EPS(TTM):3.46
EPS(LYR):3.46
ROE:40.44%
ROA:10.29%
PB:6.33
PE(LYR):16.61

Loading ...

Bristol-Myers Squibb (BMY) Receives a Hold from Citi

TIPRANKS
·
Mar 06

Berenberg Bank Reaffirms Their Buy Rating on Bloomsbury Publishing (BMY)

TIPRANKS
·
Mar 06

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 05

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 04

Bristol Myers Squibb call volume above normal and directionally bullish

TIPRANKS
·
Mar 04

Prime Medicine Publishes Corporate Presentation on Prime Editing Platform and Gene-Editing Pipeline

Reuters
·
Mar 03

Prime Medicine posts FY 2025 collaboration revenue of USD 4.6 million, up 2.9x

Reuters
·
Mar 03

Protagenic Therapeutics Names William Nichols Jr. President

Reuters
·
Mar 03

Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 a Share, Payable May 1 to Shareholders of Record on April 2

MT Newswires Live
·
Mar 03

Bristol Myers Squibb announces $0.63 per-share dividend

Reuters
·
Mar 03

Bristol Myers Squibb Announces Dividend

THOMSON REUTERS
·
Mar 03

Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now

TIPRANKS
·
Mar 01

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Janux Therapeutics Q4 net loss widens on higher R&D expenses

Reuters
·
Feb 27

Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients

Benzinga_recent_news
·
Feb 27

Is Bristol Myers Squibb (BMY) Pricing In Its 2024 Results And Product Pipeline Outlook?

Simply Wall St.
·
Feb 27

Bristol Myers Squibb reports Phase III interim wins for iza-bren in advanced TNBC

Reuters
·
Feb 26

Berenberg Bank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 26

Bristol-Myers Squibb's Risk/Reward Profile Balanced, RBC Says

MT Newswires Live
·
Feb 26

Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors

TIPRANKS
·
Feb 26